Skip to main content
. 2017 Jan 5;8(8):13304–13311. doi: 10.18632/oncotarget.14515

Figure 2. Forest plot showing hazard ratios (HR) for overall survival (OS) and 95% confidence interval (CI) for 133 EGFR-mutant NSCLC patients with BM.

Figure 2

Abbreviations: TKI + RT, tyrosine kinase inhibitors combined with radiation therapy; KPS, Karnofsky performance score; EGFR, Epidermal Growth Factor Receptor; TKI, Tyrosine Kinase Inhibitors; NSCLC, Non Small Cell Lung Cancer.